Mergers & Acquisitions


Current filters:


Popular Filters

776 to 800 of 919 results

Alliance Pharma acquires AstraZeneca antimalarial brands


UK-based specialty drug firm Alliance Pharma (AIM: APH) has acquired the antimalarial brands Paludrine,…

Alliance PharmaAstraZenecaMergers & Acquisitions

US FDA clears Amarin's Vascepa, a competitor for Lovaza


The US Food and Drug Administration has approved biotech firm Amarin's (Nasdaq: AMRN) Vascepa (icosapent…

AmarinBiotechnologyCardio-vascularGlaxoSmithKlineLovazaMergers & AcquisitionsNorth AmericaRegulationVascepa

Fresenius Kabi to acquire Fenwal


Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition, has reached a definitive…

FenwalFresenius KabiMergers & AcquisitionsPharmaceutical

Synergy Pharma and Callisto enter merger accord


USA-based biopharma groups Synergy Pharmaceuticals (Nasdaq: SGYP) and Callisto Pharmaceuticals (OTCBB:…

BiotechnologyCallisto PharmaceuticalsMergers & AcquisitionsSynergy Pharmaceuticals

Pharmaceutical supply chain in Japan sees squeezed margins


Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

SYGNIS and GENETRIX to combine subsidiary X-Pol business


German biotech firms SYGNIS Pharma AG (Frankfurt: LIOK) and GENETRIX have signed a binding term sheet…

BiotechnologyGENETRIXMergers & AcquisitionsQualiphiSYGNIS Pharma

Human Genome capitulates, accepting raised offer from GlaxoSmithKline


Confirming weekend rumors (The Pharma Letter July 16), UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

US FTC puts conditions on Novartis buy of Fougera


The USA's Federal Trade Commission said yesterday that it will require Swiss drug major drug Novartis…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalTolmar

TPG to acquire Par Pharma for $1.9 billion


Par Pharmaceutical (NYSE: PRX), a USA-based maker of generic drugs and niche innovative proprietary pharmaceuticals,…

GenericsMergers & AcquisitionsPar PharmaceuticalTPG

CritiTech sets up JV with India's Finoso Pharma for APIs


USA-based CritiTech and privately-held Indian group Finoso Pharma have formally established a joint venture…

Asia-PacificCritiTechFinoso PharmaFinotech PharmaGenericsMergers & Acquisitions

BB Biotech rejects privatization proposal by Vontobel Group


Swiss biotechnology investment fund BB Biotech (SIX: BION) has confirmed that Vontobel Group has made…

BB BiotechBiotechnologyEuropeFinancialMergers & AcquisitionsVontobel

Grifols acquires 40% of Spanish biotech firm VCN Bioscience


Spanish health care group Grifols (GRLS: MC), the world's third largest plasma product manufacturer,…

BiotechnologyGrifolsMergers & AcquisitionsOncologyVCN Bioscience

AstraZeneca buys Link Medicines neuroscience assets; enters Alzheimer's project


Anglo-Swedish drug major AstraZeneca (LSE: AZN) has acquired a portfolio of neuroscience assets from…

AstraZenecaLink MedicinesMergers & AcquisitionsNeurologicalPharmaceuticalResearch

Adcock Ingram expands in Indian pharma market buying Cosme Farma brands


South Africa's largest health care company Adcock Ingram (AIP: SJ) says it has reached an agreement to…

Adcock IngramCosme FarmaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Alchemia oncology demerger plans


Australia-based Alchemia (ASX: ACL) says it is progressing well with preparations to demerge its oncology…

AlchemiaAudeo OncologyMergers & AcquisitionsOncologyPharmaceutical

AstraZeneca completes sale of Aptium Oncology assets


Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that it has completed the previously indicated sale…

Aptium OncologyAstraZenecaMergers & AcquisitionsOncologyPharmaceutical

Spectrum extends tender offer for Allos


US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) said late Friday that it has again extended tender…

Allos TherapeuticsBiotechnologyFolotynMergers & AcquisitionsOncologySpectrum Pharmaceuticals

Bilthoven Biologicals acquired by Serum Institute of India


Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that…

Bilthoven BiologicalsBiotechnologyMergers & AcquisitionsPharmaceuticalSerum Institute of IndiaVaccines

News briefs from Merck KGaA and Sanofi


German drug major Merck KGaA )MRK: DE) revealed this morning that its Phase III EXPAND trial, which assessed…

cilengitideErbituxManagementMerck KGaAMergers & AcquisitionsPharmaceuticalResearchSanofi

Blackmores acquires FIT-BioCeuticals for A$40 million


Australia's Blackmores (ASX:BKL) says that it has agreed to acquire 100% of the issued share capital…

Asia-PacificBlackmoresFIT-BioCeuticalsMergers & AcquisitionsPharmaceutical

776 to 800 of 919 results




Back to top